The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
Blood Cancer Journal
(Mar 2024)
Calr type 1/like mutation in myelofibrosis is the most prominent predictor of momelotinib drug survival and longevity without transplant
Ayalew Tefferi,
Animesh Pardanani,
Kebede H. Begna,
Aref Al-Kali,
William J. Hogan,
Mark R. Litzow,
Rhett P. Ketterling,
Kaaren K. Reichard,
Naseema Gangat
Affiliations
Ayalew Tefferi
Division of Hematology, Mayo Clinic
Animesh Pardanani
Division of Hematology, Mayo Clinic
Kebede H. Begna
Division of Hematology, Mayo Clinic
Aref Al-Kali
Division of Hematology, Mayo Clinic
William J. Hogan
Division of Hematology, Mayo Clinic
Mark R. Litzow
Division of Hematology, Mayo Clinic
Rhett P. Ketterling
Division of Hematopathology, Mayo Clinic
Kaaren K. Reichard
Division of Hematopathology, Mayo Clinic
Naseema Gangat
Division of Hematology, Mayo Clinic
DOI
https://doi.org/10.1038/s41408-024-01028-4
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 4
Abstract
Read online
No abstracts available.
WeChat QR code
Close